HCWB HCW Biologics Inc.

Fundamentals / CIK 0001828673 / USD

HCW Biologics Inc. reported $6.70M in revenue and a net loss of $4.25M for the trailing twelve months ended September 30, 2026 (up 227.9% year over year), with a 96.6% gross margin and a -104.2% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open HCWB in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

6 fiscal years (2020 to 2025), reported in USD.

$9.80M$4.90M$0-$28.64MFY 2020 Revenue: $4.10MFY 2020 Net Income: -$5.80M2020FY 2021 Revenue: $0FY 2021 Net Income: -$12.86M2021FY 2022 Revenue: $6.72MFY 2022 Net Income: -$14.90M2022FY 2023 Revenue: $2.84MFY 2023 Net Income: -$24.99M2023FY 2024 Revenue: $2.57MFY 2024 Net Income: -$30.02M2024FY 2025 Revenue: $54KFY 2025 Net Income: -$7.96M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $54K $2.57M $2.84M $6.72M $0 $4.10M
Cost of Revenue $43K $1.61M $2.28M $4.14M $0 --
Gross Profit $11K $959K $560K $2.59M $0 --
Research & Development $5.44M $6.39M $7.68M $9.34M $8.17M $7.26M
Total Operating Expenses $13.17M $30.42M $26.28M $17.67M $13.37M $9.92M
Operating Income -$13.16M -$29.46M -$25.72M -$15.08M -$13.37M -$5.82M
EBITDA -$12.12M -$28.27M -$24.58M -$14.36M -$12.82M -$5.25M
Interest Expense $845K $654K $283K $127K $0 --
Income Before Tax -$7.96M -$30.02M -$24.99M -$14.90M -$12.86M -$5.80M
Income Tax Expense $0 $0 $0 $0 $0 $0
Net Income -$7.96M -$30.02M -$24.99M -$14.90M -$12.86M -$5.80M
Basic EPS -$63.77 -$185.72 -$167.97 -$100.78 -$165.57 -$357.53
Diluted EPS -$63.77 -$185.72 -$167.97 -$100.78 -$165.57 -$357.53
Basic Shares Outstanding 349.7K 161.7K 149.7K 149.3K 78.2K 19.8K
Diluted Shares Outstanding 349.7K 161.7K 149.7K 149.3K 78.2K 19.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $51K $122K $6.50M $27K $16K $6.5K $5.1K $395K
Cost of Revenue $27K $229K $11K $22K $12K $5.2K $4.1K $316K
Gross Profit $28K -$94K $6.53M $5.4K $3.1K $1.3K $1.0K $79K
Research & Development $1.24M $1.20M $1.26M $1.33M $1.40M $1.23M $1.48M $1.05M
Total Operating Expenses $2.62M $3.07M $3.30M $4.47M $3.30M $3.47M $1.97M $3.23M
Operating Income -$2.59M -$3.17M $3.24M -$4.46M -$3.29M -$3.46M -$1.97M -$3.15M
EBITDA -$2.47M -$3.04M $3.38M -- -$3.12M -$3.17M -$1.55M -$2.46M
Interest Expense $142K $101K $109K $212K $127K $229K $256K $260K
Income Before Tax -$3.22M -$5.22M $3.80M $719K -$4.55M -$1.93M -$2.20M --
Income Tax Expense $0 $0 $330K $0 -- -- $0 $0
Net Income -$3.22M -$5.22M $3.47M $719K -$4.55M -$1.93M -$2.20M -$3.37M
Basic EPS -$2.83 -$11.58 $2.22 -- -$12.09 -$40.72 -$11.82 --
Diluted EPS -$2.83 -$11.58 $2.22 -- -$12.09 -$40.72 -$11.82 --
Basic Shares Outstanding 2.1M 1.3M 904.5K -- 376.7K 296.7K 186.2K --
Diluted Shares Outstanding 2.1M 1.3M 904.5K -- 376.7K 296.7K 186.2K --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $1.95M $4.67M $3.60M $22.33M $11.73M $8.46M
Short-Term Investments $0 $0 $0 $9.74M $24.98M --
Cash & Short-Term Investments $1.95M $4.67M $3.60M $32.06M $36.71M $8.46M
Accounts Receivable, Net $32K $582K $1.54M $418K $133K $2.50M
Other Current Assets $78K $114K $231K $196K $1.44M $655K
Total Current Assets $2.28M $5.70M $6.40M $34.07M $40.48M $12.15M
Property, Plant & Equipment, Net $20.88M $22.91M $20.45M $10.80M $1.12M $1.62M
Long-Term Investments $1.33M $1.60M $1.60M $1.60M $11.52M $1.60M
Other Non-Current Assets $28K $28K $57K $334K $393K $34K
Total Non-Current Assets $22.24M $24.54M $22.11M $12.74M $13.03M $3.25M
Total Assets $24.52M $30.24M $28.51M $46.81M $53.51M $15.40M
Accounts Payable $13.14M $22.33M $6.17M $1.23M $224K $155K
Short-Term Debt $6.81M $6.31M $119K $38.27M -- --
Deferred Revenue (Current) $0 $0 $0 $0 -- --
Total Current Liabilities $21.06M $29.63M $8.75M $2.96M $2.32M $1.00M
Long-Term Debt -- -- $6.18M -- $0 --
Other Non-Current Liabilities $693K -- -- -- -- --
Total Non-Current Liabilities $693K $7.38M $6.30M $6.42M $0 $31.12M
Total Liabilities $21.76M $37.01M $15.05M $9.38M $2.32M $32.12M
Total Debt (incl. Leases) $6.81M $6.31M $6.33M $38.47M $0 --
Common Stock $55 $111 $3.6K $3.6K $3.6K --
Retained Earnings -$108.5M -$100.6M -$70.53M -$45.54M -$30.64M -$16.72M
Total Stockholders' Equity $2.76M -$6.77M $13.46M $37.43M $51.19M -$16.72M
Total Equity $2.76M -$6.77M $13.46M $37.43M $51.19M -$16.72M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $955K $741K $1.23M $1.95M $1.10M $2.44M $1.11M $4.67M
Short-Term Investments $0 $0 $0 $0 $0 $0 $0 $0
Cash & Short-Term Investments $955K $741K $1.23M $1.95M $1.10M $2.44M $1.11M $4.67M
Accounts Receivable, Net -- $18K $75K $32K $31K $22K $87K $582K
Other Current Assets $85K $98K $120K $78K $250K $141K $443K $114K
Total Current Assets $1.28M $1.14M $1.72M $2.28M $1.59M $2.90M $1.89M $5.70M
Property, Plant & Equipment, Net $18.96M $20.75M $20.77M $20.88M $22.50M $22.64M $22.76M $22.91M
Long-Term Investments $4.85M $4.85M $4.83M $1.33M $1.33M $3.35M $1.60M $1.60M
Other Non-Current Assets $28K $28K $28K $28K $28K $28K $28K $28K
Total Non-Current Assets $23.85M $25.63M $25.62M $22.24M $23.86M $26.01M $24.39M $24.54M
Total Assets $25.13M $26.77M $27.34M $24.52M $25.45M $28.91M $26.29M $30.24M
Accounts Payable $9.44M $10.61M $11.79M $13.14M $18.97M $19.35M $19.73M $22.33M
Short-Term Debt $6.83M $6.56M $6.58M $6.81M $6.81M $6.42M $6.23M $6.31M
Deferred Revenue (Current) $297K $348K $470K $0 -- -- -- $0
Total Current Liabilities $17.61M $18.65M $19.96M $21.06M $26.86M $26.85M $27.14M $29.63M
Other Non-Current Liabilities -- -- $693K $693K -- -- -- --
Total Non-Current Liabilities $693K $693K $1.62M $693K $693K $2.12M $7.71M $7.38M
Total Liabilities $18.30M $19.34M $21.58M $21.76M $27.55M $28.96M $34.85M $37.01M
Total Debt (incl. Leases) $6.83M $6.56M $6.58M $6.81M $6.81M $6.42M $6.23M $6.31M
Common Stock $223 $161 $673 $55 $262 $215 $4.5K $111
Retained Earnings -$113.5M -$110.3M -$105.0M -$108.5M -$109.2M -$104.7M -$102.8M -$100.6M
Total Stockholders' Equity $6.82M $7.43M $5.76M $2.76M -$2.11M -$52K -$8.56M -$6.77M
Total Equity $6.82M $7.43M $5.76M $2.76M -$2.11M -$52K -$8.56M -$6.77M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$7.96M -$30.02M -$24.99M -$14.90M -$12.86M -$5.80M
Depreciation & Amortization $1.04M $1.18M $1.14M $718K $544K $573K
Stock-Based Compensation $769K $1.01M $1.00M $1.12M $361K $22K
Change in Receivables $550K $954K -$1.12M -$285K $2.37M -$2.50M
Operating Cash Flow -$13.39M -$14.23M -$22.51M -$10.39M -$10.98M -$10.43M
Capital Expenditure $0 -$262K -$6.20M -$10.28M -$47K -$187K
Free Cash Flow -$13.39M -$14.49M -$28.72M -$20.66M -$11.02M -$10.62M
Investing Cash Flow $0 -$262K $3.80M $14.71M -$35.02M -$187K
Common Stock Issued $5.49M $6.46M $24K $16K $30K $9.9K
Financing Cash Flow $10.67M $15.57M -$15K $6.27M $49.27M $11.72M
Net Change in Cash -$2.72M $1.08M -$18.73M $10.60M $3.27M $1.10M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$3.22M -$5.22M $3.47M $719K -$4.55M -$1.93M -$2.20M -$3.37M
Depreciation & Amortization $120K $127K $142K -- $174K $292K $419K $683K
Stock-Based Compensation $364 $1.2K $10K $9.2K $205K $278K $276K $292K
Change in Receivables $18K $56K -$43K -$1.5K -$9.1K $66K $495K $70K
Operating Cash Flow -$2.62M -$3.97M -$1.58M -$3.36M -$3.24M -$3.28M -$3.51M -$2.83M
Capital Expenditure -- -- -- $0 $0 $0 $0 -$113K
Free Cash Flow -- -- -- -$3.36M -$3.24M -$3.28M -$3.51M -$2.95M
Investing Cash Flow -- -- -- $0 $0 $0 $0 -$113K
Common Stock Issued -- -- -- $4.02M $0 $1.47M $1.7K $3.96M
Financing Cash Flow $2.83M $3.48M $852K $4.21M $1.90M $4.61M -$53K $6.62M
Net Change in Cash $214K -$488K -$724K $856K -$1.34M $1.33M -$3.57M $3.68M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Gross Margin 20.0% 37.4% 19.7% 38.5% -- --
Operating Margin -24270.7% -1147.6% -905.0% -224.3% -- -142.1%
Net Profit Margin -14677.1% -1169.7% -879.5% -221.7% -- -141.5%
Return on Equity (ROE) -287.9% -- -185.7% -39.8% -25.1% --
Return on Assets (ROA) -32.5% -99.3% -87.7% -31.8% -24.0% -37.7%
Current Ratio 0.11x 0.19x 0.73x 11.52x 17.44x 12.14x
Quick Ratio 0.09x 0.18x 0.59x 10.99x 15.87x 10.94x
Debt to Equity 2.46x -- 0.47x 1.03x 0.00x --
Revenue Growth (YoY) -97.9% -9.7% -57.7% -- -100.0% --
Gross Profit Growth (YoY) -98.9% +71.2% -78.3% -- -- --
5Y Revenue / Share Growth -99.9% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Gross Margin 96.6% 96.7% 99.9% 20.0% 20.0% 20.0% 23.9% 37.4%
Operating Margin -104.2% -115.3% -121.9% -24310.5% -2812.5% -1472.3% -1656.2% -1147.8%
Net Profit Margin -63.4% -83.8% -35.0% -14677.4% -2855.8% -1368.8% -1712.8% -1169.7%
Return on Equity (ROE) -62.3% -75.2% -39.7% -287.9% -- -- -- --
Return on Assets (ROA) -16.9% -20.9% -8.4% -32.5% -47.4% -39.4% -94.2% -99.3%
Current Ratio 0.07x 0.06x 0.09x 0.11x 0.06x 0.11x 0.07x 0.19x
Quick Ratio 0.05x 0.04x 0.07x 0.09x 0.04x 0.09x 0.04x 0.18x
Debt to Equity 1.00x 0.88x 1.14x 2.46x -- -- -- --
Revenue Growth (YoY) +227.9% +1758.5% +128231.7% -93.2% -96.3% -98.9% -99.6% -70.2%
Gross Profit Growth (YoY) +800.9% -7266.9% +644710.5% -93.2% -96.3% -99.3% -99.8% -68.7%
Source: SEC EDGAR CompanyFacts (CIK 0001828673) · from March 31, 2020 Data through September 30, 2026 · synced Nov 21, 2026, 05:15 UTC · Open in terminal